Clinical Trials for NS Pharma

Explore 17 clinical trials worldwide

Showing 1-17 of 17 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: NS Pharma

Clinical Trials (17)

NCT07118709
A Study of KC1086 in Patients With Advanced Solid Tumors
PHASE1Not yet recruiting
66 participants
Started: Aug 31, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor0 locations
NCT06708741
Regime for Vitamin D Maintenance in Post-Operative Patients
PHASE3Not yet recruiting
100 participants
Started: Jan 1, 2025 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06564272
A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma
PHASE2Recruiting
30 participants
Started: Sep 27, 2024 · Completed: Apr 1, 2028
1 condition1 sponsor1 location
NCT06053814
NS-050/NCNP-03 in Boys With DMD (Meteor50)
PHASE1/PHASE2Recruiting
20 participants
Started: Sep 18, 2024 · Completed: May 31, 2027
1 condition2 sponsors18 locations
NCT05996003
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
PHASE2Recruiting
20 participants
Started: Feb 22, 2024 · Completed: Sep 11, 2026
3 conditions2 sponsors17 locations
NCT06194734
A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer
PHASE3Recruiting
490 participants
Started: Feb 5, 2024 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT06046222
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
PHASE2Recruiting
45 participants
Started: Dec 20, 2023 · Completed: Jul 31, 2026
2 conditions2 sponsors34 locations
NCT05683886
A Study of KC1036 in Patients with Advanced Thymic Tumors
PHASE2Recruiting
30 participants
Started: Feb 22, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor2 locations
NCT05970783
A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease
PHASE3Recruiting
414 participants
Started: Nov 8, 2022 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05984420
Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic Dermatitis
NARecruiting
200 participants
Started: Apr 21, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors5 locations
NCT05260385
To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors
PHASE1/PHASE2Recruiting
133 participants
Started: Jan 24, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor13 locations
NCT04687020
Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)
PHASE4Active, not recruiting
9 participants
Started: Jun 10, 2021 · Completed: Oct 31, 2032
1 condition1 sponsor5 locations
NCT04762069
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
PHASE2Active, not recruiting
210 participants
Started: May 18, 2021 · Completed: Mar 31, 2026
1 condition2 sponsors48 locations
NCT04768062
Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)
PHASE3Active, not recruiting
74 participants
Started: Apr 13, 2021 · Completed: Nov 30, 2025
1 condition2 sponsors31 locations
NCT05971355
Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic Dermatitis
NARecruiting
200 participants
Started: Mar 10, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor5 locations
NCT04387916
A Study of KC1036 in Patients with Advanced Solid Tumors
PHASE1Recruiting
207 participants
Started: Sep 4, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT04093466
A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors
PHASE1Recruiting
126 participants
Started: Apr 27, 2020 · Completed: Dec 31, 2025
1 condition4 sponsors1 location